Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zentalis Pharmaceuticals, Inc. | 10%+ Owner | Common Stock, par value $0.001 per share | 14M | $144M | $10.29 | Jun 20, 2023 | Indirect |
Aura Biosciences, Inc. | 10%+ Owner | Common Stock, par value $0.00001 per share (Common Stock) | 6.92M | $62.3M | $9.00 | Nov 9, 2023 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AURA | Aura Biosciences, Inc. | Nov 9, 2023 | 1 | $14M | 4 | Nov 9, 2023 | 10%+ Owner |
ZNTL | Zentalis Pharmaceuticals, Inc. | Jun 20, 2023 | 1 | $108M | 4 | Jun 20, 2023 | 10%+ Owner |
AURA | Aura Biosciences, Inc. | Dec 5, 2022 | 1 | $15M | 4 | Dec 7, 2022 | 10%+ Owner |
ZNTL | Zentalis Pharmaceuticals, Inc. | May 18, 2022 | 0 | $0 | 3 | Jun 3, 2022 | 10%+ Owner |
AURA | Aura Biosciences, Inc. | Nov 2, 2021 | 3 | $25M | 4 | Nov 4, 2021 | 10%+ Owner |
AURA | Aura Biosciences, Inc. | Oct 28, 2021 | 0 | $0 | 3 | Oct 28, 2021 | 10%+ Owner |